Related Experiment Video
Updated: May 21, 2026

06:21
Multi-Gene Single Nucleotide Polymorphism Detection in Gastric Cancer Based on Ion Semiconductor Sequencing Platform
Published on: May 10, 2024
A nonsense mutation in S-antigen (p.Glu306*) causes Oguchi disease
Nadia K Waheed1, Ahmed H Qavi, Sarah N Malik
1Shifa College of Medicine, Islamabad, Pakistan.
Molecular Vision
|June 6, 2012
Summary
Genetic analysis identified a novel mutation in the SAG gene causing Oguchi type 1 congenital stationary night blindness in a Pakistani patient. This finding advances understanding of inherited retinal diseases.
Area of Science:
- Ophthalmology
- Genetics
- Molecular Biology
Background:
- Congenital stationary night blindness (CSNB) is an inherited retinal disorder.
- Mizuo-Nakamura phenomenon is a characteristic symptom of Oguchi disease, a form of CSNB.
- Genetic heterogeneity underlies different types of Oguchi disease.
Observation:
- A 15-year-old Pakistani girl presented with CSNB, Mizuo-Nakamura phenomenon, dural sinus thrombosis (DST), thrombocytopenia, and systemic lupus erythematosus (SLE).
- Genetic analysis focused on the S-antigen (SAG) and rhodopsin kinase (GRK1) genes for Oguchi types 1 and 2, respectively.
- The methylenetetrahydrofolate reductase (MTHFR) C677T variation was investigated for its association with hyperhomocysteinemia.
Findings:
- A novel homozygous nonsense mutation (c.916G>T; p.Glu306*) in the SAG gene was identified as the cause of Oguchi type 1.
- The identified SAG mutation was absent or heterozygous in unaffected siblings.
- The MTHFR C677T heterozygous allele was associated with hyperhomocysteinemia in the patient and family members.
Implications:
- This study reports the first Pakistani case of Oguchi type 1 CSNB caused by a novel SAG mutation.
- The findings expand the mutational spectrum of the SAG gene in inherited retinal diseases.
- The neurologic and hematologic conditions observed in the patient are likely unrelated to the SAG gene variant.
More Related Videos
Related Concept Videos
Proteoglycans
Glycans, a class of complex heterogeneous molecules, can be covalently attached to proteins to form glycosylated proteins that regulate various physiological and pathological processes. Glycosylated proteins or glycoproteins comprise N-linked and O-linked oligosaccharides. O-glycosylation is the most common type of protein glycosylation. Here, glycans attach to the oxygen atom of the hydroxyl groups of Serine or Threonine residues. O-linked glycosylation occurs later in protein processing,...
Mutations
Overview
Mutations
Mutations are changes in the sequence of DNA. These changes can occur spontaneously or they can be induced by exposure to environmental factors. Mutations can be characterized in a number of different ways: whether and how they alter the amino acid sequence of the protein, whether they occur over a small or large area of DNA, and whether they occur in somatic cells or germline cells.
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
Mutations
Overview
Nonsense-mediated mRNA Decay
The Upf proteins that carry out nonsense-mediated decay (NMD) are found in all eukaryotic organisms, including humans. Each protein has an individual role, but they need to work in collaboration. Upf1 is an ATP-dependent RNA helicase that unwinds the RNA helix. Because Upf1 can unwind any RNA, Upf2 and Upf3 are required to help Upf1 discriminate between nonsense and normal mRNAs.
Usually, Upf3 binds to an Exon Junction Complex (EJC) at mRNA splice sites. If a ribosome fully translates the mRNA,...
Usually, Upf3 binds to an Exon Junction Complex (EJC) at mRNA splice sites. If a ribosome fully translates the mRNA,...
Translation
Lesson: Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life

